These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. POMA analyses as new efficient bioinformatics' platform to predict and optimise bioactivity of synthesized 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues. Ahsan MJ; Govindasamy J; Khalilullah H; Mohan G; Stables JP Bioorg Med Chem Lett; 2012 Dec; 22(23):7029-35. PubMed ID: 23099090 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles. Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives. Ali MA; Yar MS; Kumar M; Pandian GS Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents. Ali MA; Yar MS Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel 6, 7-dimethoxy-3-(4-pyridyl)-2,3,3a,4-tetrahydroindeno[1,2-c]pyrazol-2-yl-4-substituted phenylmethanone/ethanone derivatives. Ali MA; Ismail R; Choon TS; Elumalai M; Kumar S; Osman H; Govidasamy J; Yadav R; Yadav G; Kour R; Vyas S J Enzyme Inhib Med Chem; 2012 Feb; 27(1):155-9. PubMed ID: 21635209 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Ali MA; Shaharyar M; Siddiqui AA Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione. Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines. Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324 [TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis. Sriram D; Yogeeswari P; Yelamanchili Priya D Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis. Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962 [TBL] [Abstract][Full Text] [Related]
18. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity. Nayak N; Ramprasad J; Dalimba U Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents. De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577 [TBL] [Abstract][Full Text] [Related]